🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Continuous Renal Replacement Therapy (CRRT)

WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients NCT07447791NA1 site📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: low intensity of CRRT, usual intensity of CRRT Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Vantive Health LLC · Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT NCT07807410NA1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: oXiris Hemofilter Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury NCT06229990Phase 41 site📍 Chiang Mai Chiang Mai University · Tests: Furosemide Injection Nafamostat Efficacy in Phase 3 Registrational CRRT Study NCT06150742NA10 sites📍 Los Angeles📍 Orlando📍 Detroit Talphera, Inc · Tests: Niyad (nafamostat mesylate), Placebo (0.9% NaCl) Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) NCT07469072Phase 21 site📍 Guangzhou Zhujiang Hospital · Tests: Nafamostat Low-Dose Group, Nafamostat High-Dose Group Effect of High Versus Standard Protein Intake in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy NCT07596043NA1 site📍 Bangkok Chulalongkorn University · Tests: High protein group, Standard protein group To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT NCT06440759NA1 site📍 Kubang Kerian Mohd Zulfakar Mazlan, MBBS · Tests: oXiris filter, M100 filter Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy NCT07346118NA2 sites📍 Bangkok📍 Bangkok Chulalongkorn University · Tests: mVExUS-guided fluid management OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study NCT07419802n/a1 site📍 Riga Pauls Stradins Clinical University Hospital · Tests: AN69-polyethylenimine hemofilter (Oxiris®) used for continuous veno-venous hemofiltration (CVVH) Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI ) NCT06021288NA2 sites📍 Münster📍 Tübingen Universität Münster · Tests: Effluent dose of CRRT Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy NCT07514650NA1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: continuous renal replacement therapy Intra-Abdominal Pressure Changes During Continuous Renal Replacement Therapy in Critically Ill Patients NCT07823387n/a1 site📍 Bursa Bursa Yuksek Ihtisas Training and Research Hospital · Tests: Intravesical Intra-abdominal Pressure Measurement Post-Filter Hematocrit NCT07293936NA1 site📍 Iowa City Gwyndolyn M. Radford · Tests: Calculated Post-Filter Hematocrit, Measured Post-Filter Hematocrit Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. NCT06174610n/a1 site📍 Opole Uniwersytecki Szpital Kliniczny w Opolu · Tests: Measurement of Renal Resistive Index
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy